Metrics as of 10/15/2026, 10:01 AM (Berlin time), refresh in progress.
PROCEPT BioRobotics Stock
PROCEPT BioRobotics Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Larry L. Wood
- Employees
- 888
- Market cap
- $997 M
- IPO
- 15/09/2021
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system…
PROCEPT BioRobotics stock: price history
1D
-8.3%
1W
-2.2%
1M
-16.7%
6M
-31.8%
YTD
-44.3%
1Y
-48.4%
2Y
-76.0%
5Y
-59.8%
10Y
–
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~69% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Double top
BearishThe price failed at a similar high twice, with a pullback in between. This M-shaped pattern is a classic reversal signal from an uptrend into a downtrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about PROCEPT BioRobotics
Analyst assessment of PROCEPT BioRobotics
PRICE TARGET LOW
US$19.00
CONSENSUS
US$23.00
MEDIAN
US$21.00
PRICE TARGET HIGH
US$30.00
0
STRONG BUY
9
BUY
6
HOLD
1
SELL
0
STRONG SELL
16
TOTAL · Buy
As of: 05/08/2026
PROCEPT BioRobotics stock metrics
P/E
-9.03
P/B
2.91
EV/EBITDA
-8.55
RETURN ON EQUITY
-7.9%
NET MARGIN
-28.4%
DEBT/EQUITY
0.23
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
96.0%
FLOAT SHARES
54,620,000
AVG. DAILY VOLUME (30D)
1,398,995
Insider transactions (SEC)
Mack Michael
Templin Barry L
Nouri Alaleh
Waters Kevin
Nouri Alaleh
Institutional holders
Comparable stocks
Frequently asked questions about PROCEPT BioRobotics stock
What does PROCEPT BioRobotics do?
PROCEPT BioRobotics Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Larry L. Wood, the company employs around 888 people.
The IPO was on 15/09/2021; the stock trades on NASDAQ under the ticker PRCT.
What do analysts say about PROCEPT BioRobotics stock?
16 analysts rate the stock, the consensus is Buy (as of 05/08/2026).
The average price target is US$23.00, ranging from US$19.00 to US$30.00, with a median of US$21.00.
This is an external assessment, not a statement by Market Jury.
When does PROCEPT BioRobotics report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 69% stronger than usual.
Does PROCEPT BioRobotics pay a dividend?
No, PROCEPT BioRobotics currently does not pay a dividend.
Which stocks are comparable to PROCEPT BioRobotics?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get PROCEPT BioRobotics stock analyzed?
Clicking "Analyze stock" lets five strategies assess PROCEPT BioRobotics against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.